Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Cytomegalovirus

methylprednisolone hemisuccinate has been researched along with Cytomegalovirus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Falagas, ME; Freeman, R; Griffith, J; Rohrer, R; Ruthazer, R; Snydman, DR; Werner, BG1

Trials

1 trial(s) available for methylprednisolone hemisuccinate and Cytomegalovirus

ArticleYear
Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Clinical transplantation, 1997, Volume: 11, Issue:5 Pt 1

    Topics: Adolescent; Adult; Antilymphocyte Serum; Blood Transfusion; Boston; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Longitudinal Studies; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multivariate Analysis; Placebos; Proportional Hazards Models; Survival Rate; Time Factors

1997